Abstract
We report a 57-year-old man with recurrent meningoencephalitis resulting in bouts of altered consciousness, encephalopathy, tremors, focal seizures, and paraparesis. The neurological manifestations were accompanied by fever and leukocytosis in the absence of other systemic manifestations. MRI abnormalities of the brain, brainstem, spinal cord and meninges and CSF pleocytosis and elevated protein were observed. Exhaustive studies failed to reveal an etiology. Brain biopsy revealed nodules of neutrophils and macrophages, but no vasculitis. The lesions were not vasocentric as would be expected with neuro-Behcet’s disease and neuro-Sweet’s disease. The disorder was responsive to high-dose corticosteroid therapy and, ultimately, to anakinra, an IL-1α and IL-1β receptor antagonist.
Similar content being viewed by others
References
Saracino D, Allegorico L, Barbarulo AM, Pollo B, Giaccone G, D’Amico A, D’Incerti L, Bugiani O, Di Iorio G, Sampaolo S et al (2018) Neuro-Behcet’s disease presenting as an isolated progressive cognitive and behavioral syndrome. Neurocase 24(5–6):238–241
International Team for the Revision of the International Criteria for Behcet’s D (2014) The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347
von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31(4):535–556 (quiz 557–560)
Arai Y, Kohno S, Takahashi Y, Miyajima Y, Tsutusi Y (2006) Autopsy case of neuro-Behcet’s disease with multifocal neutrophilic perivascular inflammation. Neuropathology 26(6):579–585
Charlson R, Kister I, Kaminetzky D, Shvartsbeyn M, Meehan SA, Mikolaenko I (2015) CNS neutrophilic vasculitis in neuro-Sweet disease. Neurology 85(9):829–830
Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A et al (2019) The right place of interleukin-1 inhibitors in the treatment of Behcet’s syndrome: a systematic review. Rheumatol Int 39(6):971–990
Giacomelli R, Sota J, Ruscitti P, Campochiaro C, Colafrancesco S, Dagna L, Iacono D, Iannone F, Lopalco G, Sfriso P et al (2021) The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature. Clin Exp Rheumatol 39(1):187–195
Hennig S, Bayegan K, Uffmann M, Thalhammer F, Winkler S (2012) Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review. Rheumatol Int 32(6):1801–1804
Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M (2018) The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev 17(8):768–774
Swart JF, Barug D, Mohlmann M, Wulffraat NM (2010) The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. Expert Opin Biol Ther 10(12):1743–1752
Funding
There were no sources of funding for this case report.
Author information
Authors and Affiliations
Contributions
JB was responsible for acquisition of data, the initial draft of the manuscript, and editing the manuscript. CM was responsible for acquisition of data and editing the manuscript. PM was responsible for acquisition of data and editing the manuscript. RK was responsible for acquisition of data and editing the manuscript. ZM was responsible for acquisition of data and editing the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflicts of interest relevant to this manuscript.
Ethical statement
The subject of this case report and his family have provided expressed written consent for its publication.
Informed consent
The authors have obtained informed consent from the patient to describe his illness.
Rights and permissions
About this article
Cite this article
Berger, J.R., Markowitz, C., Merkel, P.A. et al. Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra. J Neurol 268, 2995–2999 (2021). https://doi.org/10.1007/s00415-021-10431-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10431-x